Riskpilot← Back to searchSign inGet full accessNirvana Health Lab AB
ABActiveOrg 5568007875Åsögatan 166 BvDay spa, sauna and steam bath activities · NACE 9623Est. 20101 employees
Revenue 2025
SEK 571K
-23% vs 2024
EBITDA margin
-2.5%
-130% vs 2024
Equity ratio
34.4%
Financial strength
Net profit 2025
SEK -23K
-162% vs 2024
| Revenue | SEK 571K | -23% |
| EBITDA | SEK -14K | -130% |
| Net profit | SEK -23K | -162% |
| Total assets | SEK 189K | -32% |
| Equity | SEK 65K | -26% |
| Employees | 1 | — |
Legal name
Nirvana Health Lab AB
Org number
5568007875
Legal form
Aktiebolag
NACE code
9623 · Day spa, sauna and steam bath activities
Founded
15 februari 2010
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva friskvård och terapi (bl a massage, healing, kinesiologi, meditation, yoga och solterapi), bedriva utbildning i bl a meditation, yoga massage och andra terapiformer, bedriva import och försäljning av friskvårdsprodukter, bedriva andra- handsuthyrning av lokaler samt därmed förenlig verksamhet.
Address
Åsögatan 166 Bv
Email
nirvana.stockholm@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 579 | 575 | 769 | 740 | 571 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −53 | −117 | −6 | 46 | −14 |
| Depreciation & amort. | −8 | −8 | −8 | −8 | −8 |
| EBIT | −61 | −125 | −14 | 38 | −22 |
| Net financials | −3 | −3 | −3 | −1 | −2 |
| Profit before tax | −64 | −128 | −16 | 37 | −23 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −64 | −128 | −16 | 37 | −23 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 411 | 366 | 454 | 276 | 189 |
| Equity | 140 | 52 | 51 | 88 | 65 |
| Long-term debt | 169 | 176 | 235 | 151 | 98 |
| Short-term debt | 102 | 137 | 168 | 37 | 26 |
| Total debt | 271 | 313 | 403 | 188 | 124 |
EBITDA margin
-2.5%
This company
15.8%
Market median
-116% vs market
20212025
Equity ratio
34.4%
This company
38.2%
Market median
+10% vs market
20212025
Return on equity
-35.4%
This company
18.4%
Market median
-292% vs market
20212025
Net profit margin
-4.0%
This company
8.1%
Market median
-149% vs market
20212025
Asset turnover
3.02×
This company
1.12×
Market median
+170% vs market
20212025
Debt / equity
1.91×
This company
0.62×
Market median
-208% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Audit | 2022 | |
LC Chief Executive Officer | Chief Executive Officer | 2021 |
| Former (1) | ||
BI Chief Executive Officer | Chief Executive Officer | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Nirvana Health Lab AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Johan Erik Eriksson Isbrand | Audit | 0 companies |
| Leif Christer Ohrling | Chief Executive Officer | 0 companies |
| Birgitta Ingrid Ohrling | Chief Executive Officer | 0 companies |
| Andreas Christian John Lindberg | Deputy Board Member | 0 companies |
| Nils Robert Frishammar | Deputy Board Member | 0 companies |